Pfizer says trials on lymphoma drug ‘positive,’ extends life of patients
HQ Team March 12, 2024: Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded
HQ Team March 12, 2024: Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded
HQ Team March 12, 2024: The FDA has issued revised draft guidance for early treatment of Alzheimer’s disease with drugmakers told to focus
HQ Team March 11, 2024: Swimming robots — smaller than grains of sand — have enough computing power to perform a task on
HQ Team March 11, 2024: Europe, one of the fastest-warming continents in the world, is not keeping pace with a rapidly growing climate
HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company
HQ Team March 7, 2024: The FDA has approved Pfizer’s Besponsa drug for pediatric patients aged one year and above to treat acute
HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but
HQ Team March 7, 2024: Greenhouse gas emissions will rob the Arctic ice as early as the 2030s in summer, resulting in a significant impact
HQ Team March 7, 2024: A chip, developed by the US-based National Institute of Standards and Technology, to convert light into microwaves, can